Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Sarasota, FL
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Chicago, IL
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Indianapolis, IN
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Boone, NC
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Boone, NC
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Durham, NC
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Toledo, OH
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
San Antonio, TX
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Norfolk, VA
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Mechanisms That Produce the Leg Dysfunction of Claudication (Leg Pain and Limping During Walking) and Treatment Strategies for the Care of Patients With Claudication
Mitochondrial Dysfunction, Oxidative Damage and Inflammation in Claudication
Status: Enrolling
Updated:  9/22/2017
Omaha VA Medical Center
mi
from
Omaha, NE
Mechanisms That Produce the Leg Dysfunction of Claudication (Leg Pain and Limping During Walking) and Treatment Strategies for the Care of Patients With Claudication
Mitochondrial Dysfunction, Oxidative Damage and Inflammation in Claudication
Status: Enrolling
Updated: 9/22/2017
Omaha VA Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Marin General Hospital
mi
from
Greenbrae, CA
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Marin General Hospital
mi
from
Greenbrae, CA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Florida Hospital
mi
from
Orlando, FL
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Loyola University Medical Center
mi
from
Maywood, IL
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Lahey Clinic Medical Center
mi
from
Burlington, MA
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Lahey Clinic Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
St. Luke's Roosevelt Hospital
mi
from
New York, NY
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Ohio State University Medical Center
mi
from
Columbus, OH
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Riverside Methodist Hospital
mi
from
Columbus, OH
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Medical University of South Carolina
mi
from
Charleston, SC
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
The Heart Hospital Baylor Plano Baylor Research Institute
mi
from
Plano, TX
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
The Heart Hospital Baylor Plano Baylor Research Institute
mi
from
Plano, TX
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  9/22/2017
Hospital Sao Paulo
mi
from
Sao Paulo,
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 9/22/2017
Hospital Sao Paulo
mi
from
Sao Paulo,
Click here to add this to my saved trials
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
Status: Enrolling
Updated:  9/25/2017
University of California, Berkeley School of Public Health
mi
from
Berkeley, CA
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
Status: Enrolling
Updated: 9/25/2017
University of California, Berkeley School of Public Health
mi
from
Berkeley, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
Dual Imaging Using High-definition Intravascular Ultrasound and Optical Coherence Tomography to Guide Percutaneous Coronary Intervention
Status: Enrolling
Updated:  9/25/2017
Columbia University
mi
from
New York, NY
Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
Dual Imaging Using High-definition Intravascular Ultrasound and Optical Coherence Tomography to Guide Percutaneous Coronary Intervention
Status: Enrolling
Updated: 9/25/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated:  9/26/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated: 9/26/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated:  9/26/2017
South Shore Medical Group
mi
from
Milton, MA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated: 9/26/2017
South Shore Medical Group
mi
from
Milton, MA
Click here to add this to my saved trials
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
Status: Enrolling
Updated:  9/29/2017
Penn State University
mi
from
University Park, PA
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
Status: Enrolling
Updated: 9/29/2017
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Alexander City, AL
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Alexander City, AL
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Auburn, AL
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Auburn, AL
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Mobile, AL
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Mobile, AL
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Cottonwood, AZ
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Cottonwood, AZ
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Mesa, AZ
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Fort Smith, AR
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Jonesboro, AR
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Little Rock, AR
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Little Rock, AR
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Anaheim, CA
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Berkeley, CA
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Berkeley, CA
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Chula Vista, CA
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
El Cajon, CA
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated:  9/29/2017
Clinical Research Facility
mi
from
Fresno, CA
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Status: Enrolling
Updated: 9/29/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials